ArticleWorld journal of urology2026
Litigation in paediatric urology within the National Health Service (NHS) England: an analysis of costs and causes.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo provide a national evaluation of contemporary litigation trends within Paediatric Urology within National Health Service (NHS) England by examining long-term trends, the financial burden and the underlying causes of successful claims over the last 19 years. MATERIALS AND
methodsLitigation data were obtained from NHS Resolution through a Freedom of Information (FOI) Act 2000 request, from 2006/2007 to 2024/2025. For all paediatric urology cases (patients < 18 years), information was collected on the total number of claims, the number of which were successful, and the associated costs of damages and legal fees. Successful claims were reviewed according to the recorded primary cause and the primary injury sustained.
resultsIn total, 216 litigation claims were submitted in Paediatric Urology during the study period, of which 134 (62%) were successful. Damages paid amounted to £5.32 million. The number of claims rose 3.6-fold over the 19-year-period. Damages increased 2.2-fold, from £195,750 in 2010/2011 to £441,410 in 2024/2025. The leading causes of successful claims were failure or delay in diagnosis (29.1%, 39/134), failure or delay in treatment (24.6%, 33/134), and inappropriate treatment (4.4%, 6/134). Operative factors accounted for 9.7% (13/134), while non-operative causes represented 66.41% (89/134). The most common primary injuries were removal of a testicle (36.5%, 49/134), additional or unnecessary procedures (17.1%, 23/134), unnecessary pain (8.9%, 12/134), and renal damage or failure (6.2%, 9/134).
conclusionBoth total and successful Paediatric Urology claims have progressively risen steadily across NHS England. Most stem from non-operative issues potentially influenced by extended waiting times. Improving clinician education, promoting learning from avoidable incidents, and ongoing monitoring are essential to mitigate risks, improve patient outcomes, and reduce medicolegal costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.